TrialJournal of diabetes investigation2019

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.

Kazuno Omori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.